The Supplementation Therapy in Autism and Response to Treatment Study
Is a
Allocation Type
NA
0
Health Conditions in Trial
Intervention Model
Single Group Assignment
0
Intervention Name
Oral Ultramicronized-Palmitoylethanolamide (um-PEA; 600 mg per day) in tablet form
0
Interventional Trial Phase
Not Applicable
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Dietary Supplement
0
Last Updated
January 2, 2024
0
Masking Type
None (Open Label)
0
Primary Completion Date
2025
0
Trial Recruitment Size
20
0
Trial Sponsor
Clinical Trial Start Date
September 1, 2023
0
Study Completion Date
2026
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
The Supplementation Therapy in Autism and Response to Treatment (START) Study
0
Official Website
Find more entities like The Supplementation Therapy in Autism and Response to Treatment Study
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.